Abstract CT160: The integration of PD1 blockade with epigenetic therapy is highly active and safe in heavily treated patients with T-cell lymphomaEnrica Marchi, Owen A. O’Connor, Ahmed Sawas et al.|Cancer Research|2020Cited by 4